Theochron

Acute Bronchitis, Bronchospasm, Asthma + 8 more
Treatment
4 FDA approvals
20 Active Studies for Theochron

What is Theochron

TheophyllineThe Generic name of this drug
Treatment SummaryTheophylline is a drug derived from tea that can be used as a diuretic, muscle relaxant, and bronchodilator. It works by blocking certain receptors, inhibiting an enzyme called phosphodiesterase, and activating histone deacetylase. It is sold under the brand names Uniphyl and Theochron and is mainly used to treat asthma, bronchospasm, and chronic obstructive pulmonary disease (COPD).
Elixophyllinis the brand name
image of different drug pills on a surface
Theochron Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Elixophyllin
Theophylline
1979
114

Approved as Treatment by the FDA

Theophylline, commonly known as Elixophyllin, is approved by the FDA for 4 uses like Bronchoconstriction and Chronic Bronchitis .
Bronchoconstriction
Chronic Bronchitis
Asthma
Lung Disorder

Effectiveness

How Theochron Affects PatientsTheophylline is a drug that is chemically similar to caffeine and theobromine. It is used to relieve symptoms of asthma such as bronchospasm. Theophylline works in two ways: it relaxes the airways to make breathing easier, and also helps prevent the airways from becoming inflamed or irritated by external stimuli.
How Theochron works in the bodyTheophylline works to open up airways and reduce airway sensitivity. This is done by blocking an enzyme that breaks down a chemical called cyclic AMP, which is responsible for tightening the airways. It also binds to adenosine receptors, preventing the airways from constricting. Finally, it stops inflammation genes from being activated, reducing inflammation in the airways.

When to interrupt dosage

The measure of Theochron is contingent upon the recognized affliction, including Bronchodilation, Bronchoconstriction and Chronic Obstructive Pulmonary Disease (COPD). The dosage fluctuates according to the technique of delivery showcased in the table below.
Condition
Dosage
Administration
Asthma
, 8.0 mg/mL, 0.8 mg/mL, 1.6 mg/mL, 300.0 mg, 200.0 mg, 100.0 mg, 400.0 mg, 450.0 mg, 600.0 mg, 50.0 mg, 250.0 mg, 500.0 mg, 125.0 mg, 70.0 mg, 140.0 mg, 118.0 mg, 2.0 mg/mL, 4.0 mg/mL, 3.2 mg/mL, 175.0 mg, 65.0 mg, 75.0 mg, 350.0 mg, 130.0 mg, 0.4 mg/mL, 7.0 mg/mL
, Oral, Solution, Solution - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Tablet, extended release, Tablet, extended release - Oral, Liquid, Liquid - Oral, Tablet, Tablet - Oral, Capsule, extended release, Capsule, extended release - Oral, Kit, Elixir, Elixir - Oral, Syrup, Syrup - Oral, Capsule - Oral, Capsule, Injection, Injection - Intravenous, Solution - Intravenous
Chronic Obstructive Pulmonary Disease
, 8.0 mg/mL, 0.8 mg/mL, 1.6 mg/mL, 300.0 mg, 200.0 mg, 100.0 mg, 400.0 mg, 450.0 mg, 600.0 mg, 50.0 mg, 250.0 mg, 500.0 mg, 125.0 mg, 70.0 mg, 140.0 mg, 118.0 mg, 2.0 mg/mL, 4.0 mg/mL, 3.2 mg/mL, 175.0 mg, 65.0 mg, 75.0 mg, 350.0 mg, 130.0 mg, 0.4 mg/mL, 7.0 mg/mL
, Oral, Solution, Solution - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Tablet, extended release, Tablet, extended release - Oral, Liquid, Liquid - Oral, Tablet, Tablet - Oral, Capsule, extended release, Capsule, extended release - Oral, Kit, Elixir, Elixir - Oral, Syrup, Syrup - Oral, Capsule - Oral, Capsule, Injection, Injection - Intravenous, Solution - Intravenous
Chronic Bronchitis
, 8.0 mg/mL, 0.8 mg/mL, 1.6 mg/mL, 300.0 mg, 200.0 mg, 100.0 mg, 400.0 mg, 450.0 mg, 600.0 mg, 50.0 mg, 250.0 mg, 500.0 mg, 125.0 mg, 70.0 mg, 140.0 mg, 118.0 mg, 2.0 mg/mL, 4.0 mg/mL, 3.2 mg/mL, 175.0 mg, 65.0 mg, 75.0 mg, 350.0 mg, 130.0 mg, 0.4 mg/mL, 7.0 mg/mL
, Oral, Solution, Solution - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Tablet, extended release, Tablet, extended release - Oral, Liquid, Liquid - Oral, Tablet, Tablet - Oral, Capsule, extended release, Capsule, extended release - Oral, Kit, Elixir, Elixir - Oral, Syrup, Syrup - Oral, Capsule - Oral, Capsule, Injection, Injection - Intravenous, Solution - Intravenous
Chronic bronchial inflammation
, 8.0 mg/mL, 0.8 mg/mL, 1.6 mg/mL, 300.0 mg, 200.0 mg, 100.0 mg, 400.0 mg, 450.0 mg, 600.0 mg, 50.0 mg, 250.0 mg, 500.0 mg, 125.0 mg, 70.0 mg, 140.0 mg, 118.0 mg, 2.0 mg/mL, 4.0 mg/mL, 3.2 mg/mL, 175.0 mg, 65.0 mg, 75.0 mg, 350.0 mg, 130.0 mg, 0.4 mg/mL, 7.0 mg/mL
, Oral, Solution, Solution - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Tablet, extended release, Tablet, extended release - Oral, Liquid, Liquid - Oral, Tablet, Tablet - Oral, Capsule, extended release, Capsule, extended release - Oral, Kit, Elixir, Elixir - Oral, Syrup, Syrup - Oral, Capsule - Oral, Capsule, Injection, Injection - Intravenous, Solution - Intravenous
Bronchospasm
, 8.0 mg/mL, 0.8 mg/mL, 1.6 mg/mL, 300.0 mg, 200.0 mg, 100.0 mg, 400.0 mg, 450.0 mg, 600.0 mg, 50.0 mg, 250.0 mg, 500.0 mg, 125.0 mg, 70.0 mg, 140.0 mg, 118.0 mg, 2.0 mg/mL, 4.0 mg/mL, 3.2 mg/mL, 175.0 mg, 65.0 mg, 75.0 mg, 350.0 mg, 130.0 mg, 0.4 mg/mL, 7.0 mg/mL
, Oral, Solution, Solution - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Tablet, extended release, Tablet, extended release - Oral, Liquid, Liquid - Oral, Tablet, Tablet - Oral, Capsule, extended release, Capsule, extended release - Oral, Kit, Elixir, Elixir - Oral, Syrup, Syrup - Oral, Capsule - Oral, Capsule, Injection, Injection - Intravenous, Solution - Intravenous
Bronchoconstriction
, 8.0 mg/mL, 0.8 mg/mL, 1.6 mg/mL, 300.0 mg, 200.0 mg, 100.0 mg, 400.0 mg, 450.0 mg, 600.0 mg, 50.0 mg, 250.0 mg, 500.0 mg, 125.0 mg, 70.0 mg, 140.0 mg, 118.0 mg, 2.0 mg/mL, 4.0 mg/mL, 3.2 mg/mL, 175.0 mg, 65.0 mg, 75.0 mg, 350.0 mg, 130.0 mg, 0.4 mg/mL, 7.0 mg/mL
, Oral, Solution, Solution - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Tablet, extended release, Tablet, extended release - Oral, Liquid, Liquid - Oral, Tablet, Tablet - Oral, Capsule, extended release, Capsule, extended release - Oral, Kit, Elixir, Elixir - Oral, Syrup, Syrup - Oral, Capsule - Oral, Capsule, Injection, Injection - Intravenous, Solution - Intravenous
Bronchodilation
, 8.0 mg/mL, 0.8 mg/mL, 1.6 mg/mL, 300.0 mg, 200.0 mg, 100.0 mg, 400.0 mg, 450.0 mg, 600.0 mg, 50.0 mg, 250.0 mg, 500.0 mg, 125.0 mg, 70.0 mg, 140.0 mg, 118.0 mg, 2.0 mg/mL, 4.0 mg/mL, 3.2 mg/mL, 175.0 mg, 65.0 mg, 75.0 mg, 350.0 mg, 130.0 mg, 0.4 mg/mL, 7.0 mg/mL
, Oral, Solution, Solution - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Tablet, extended release, Tablet, extended release - Oral, Liquid, Liquid - Oral, Tablet, Tablet - Oral, Capsule, extended release, Capsule, extended release - Oral, Kit, Elixir, Elixir - Oral, Syrup, Syrup - Oral, Capsule - Oral, Capsule, Injection, Injection - Intravenous, Solution - Intravenous
Airway secretion clearance therapy
, 8.0 mg/mL, 0.8 mg/mL, 1.6 mg/mL, 300.0 mg, 200.0 mg, 100.0 mg, 400.0 mg, 450.0 mg, 600.0 mg, 50.0 mg, 250.0 mg, 500.0 mg, 125.0 mg, 70.0 mg, 140.0 mg, 118.0 mg, 2.0 mg/mL, 4.0 mg/mL, 3.2 mg/mL, 175.0 mg, 65.0 mg, 75.0 mg, 350.0 mg, 130.0 mg, 0.4 mg/mL, 7.0 mg/mL
, Oral, Solution, Solution - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Tablet, extended release, Tablet, extended release - Oral, Liquid, Liquid - Oral, Tablet, Tablet - Oral, Capsule, extended release, Capsule, extended release - Oral, Kit, Elixir, Elixir - Oral, Syrup, Syrup - Oral, Capsule - Oral, Capsule, Injection, Injection - Intravenous, Solution - Intravenous
Lung Disorder
, 8.0 mg/mL, 0.8 mg/mL, 1.6 mg/mL, 300.0 mg, 200.0 mg, 100.0 mg, 400.0 mg, 450.0 mg, 600.0 mg, 50.0 mg, 250.0 mg, 500.0 mg, 125.0 mg, 70.0 mg, 140.0 mg, 118.0 mg, 2.0 mg/mL, 4.0 mg/mL, 3.2 mg/mL, 175.0 mg, 65.0 mg, 75.0 mg, 350.0 mg, 130.0 mg, 0.4 mg/mL, 7.0 mg/mL
, Oral, Solution, Solution - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Tablet, extended release, Tablet, extended release - Oral, Liquid, Liquid - Oral, Tablet, Tablet - Oral, Capsule, extended release, Capsule, extended release - Oral, Kit, Elixir, Elixir - Oral, Syrup, Syrup - Oral, Capsule - Oral, Capsule, Injection, Injection - Intravenous, Solution - Intravenous
Acute Bronchitis
, 8.0 mg/mL, 0.8 mg/mL, 1.6 mg/mL, 300.0 mg, 200.0 mg, 100.0 mg, 400.0 mg, 450.0 mg, 600.0 mg, 50.0 mg, 250.0 mg, 500.0 mg, 125.0 mg, 70.0 mg, 140.0 mg, 118.0 mg, 2.0 mg/mL, 4.0 mg/mL, 3.2 mg/mL, 175.0 mg, 65.0 mg, 75.0 mg, 350.0 mg, 130.0 mg, 0.4 mg/mL, 7.0 mg/mL
, Oral, Solution, Solution - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Tablet, extended release, Tablet, extended release - Oral, Liquid, Liquid - Oral, Tablet, Tablet - Oral, Capsule, extended release, Capsule, extended release - Oral, Kit, Elixir, Elixir - Oral, Syrup, Syrup - Oral, Capsule - Oral, Capsule, Injection, Injection - Intravenous, Solution - Intravenous
Emphysema
, 8.0 mg/mL, 0.8 mg/mL, 1.6 mg/mL, 300.0 mg, 200.0 mg, 100.0 mg, 400.0 mg, 450.0 mg, 600.0 mg, 50.0 mg, 250.0 mg, 500.0 mg, 125.0 mg, 70.0 mg, 140.0 mg, 118.0 mg, 2.0 mg/mL, 4.0 mg/mL, 3.2 mg/mL, 175.0 mg, 65.0 mg, 75.0 mg, 350.0 mg, 130.0 mg, 0.4 mg/mL, 7.0 mg/mL
, Oral, Solution, Solution - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Tablet, extended release, Tablet, extended release - Oral, Liquid, Liquid - Oral, Tablet, Tablet - Oral, Capsule, extended release, Capsule, extended release - Oral, Kit, Elixir, Elixir - Oral, Syrup, Syrup - Oral, Capsule - Oral, Capsule, Injection, Injection - Intravenous, Solution - Intravenous

Warnings

There are 20 known major drug interactions with Theochron.
Common Theochron Drug Interactions
Drug Name
Risk Level
Description
Acenocoumarol
Major
The metabolism of Acenocoumarol can be decreased when combined with Theophylline.
Aminophylline
Major
The metabolism of Aminophylline can be decreased when combined with Theophylline.
Axitinib
Major
The metabolism of Axitinib can be decreased when combined with Theophylline.
Bendamustine
Major
The metabolism of Bendamustine can be decreased when combined with Theophylline.
Brigatinib
Major
The metabolism of Brigatinib can be decreased when combined with Theophylline.
Theochron Toxicity & Overdose RiskSigns of an overdose on aripiprazole include seizures, abnormal heart rhythms, and gastrointestinal effects.
image of a doctor in a lab doing drug, clinical research

Theochron Novel Uses: Which Conditions Have a Clinical Trial Featuring Theochron?

280 active trials are currently analyzing the potential of Theochron to provide Bronchodilation, relief from Chronic Bronchitis and Asthma management.
Condition
Clinical Trials
Trial Phases
Bronchoconstriction
0 Actively Recruiting
Emphysema
9 Actively Recruiting
Phase 3, Phase 1, Phase 2, Not Applicable
Chronic bronchial inflammation
0 Actively Recruiting
Bronchodilation
0 Actively Recruiting
Airway secretion clearance therapy
0 Actively Recruiting
Chronic Bronchitis
5 Actively Recruiting
Not Applicable, Phase 3, Phase 4
Bronchospasm
0 Actively Recruiting
Acute Bronchitis
11 Actively Recruiting
Not Applicable, Phase 3, Phase 4, Phase 2
Chronic Obstructive Pulmonary Disease
102 Actively Recruiting
Phase 3, Not Applicable, Phase 1, Phase 2, Early Phase 1, Phase 4
Lung Disorder
6 Actively Recruiting
Not Applicable, Phase 1, Phase 2
Asthma
155 Actively Recruiting
Not Applicable, Phase 1, Phase 2, Phase 4, Early Phase 1, Phase 3

Theochron Reviews: What are patients saying about Theochron?

4Patient Review
10/7/2007
Theochron for Emphysema
I only took 100mg of this medication, but I found it really helped with my breathing. I also have asthma, so this was a big relief for me.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about theochron

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the side effect of theophylline?

"You may experience some of the following side effects: nausea/vomiting, stomach/abdominal pain, headache, trouble sleeping, diarrhea, irritability, restlessness, nervousness, shaking, or increased urination."

Answered by AI

Is theophylline a steroid?

"Theophylline is a bronchodilator that helps to manage asthma by expanding airways. It is not a steroid medicine."

Answered by AI

Why is theophylline no longer used?

"Oral theophylline is not commonly used to treat chronic obstructive pulmonary disease (COPD) because it can cause undesirable side effects, especially at high doses. Newer drugs have been developed that are more effective and have fewer side effects."

Answered by AI

What is the indication of theophylline?

"This medication is meant to treat the symptoms of serious lung diseases like asthma, emphysema, and chronic bronchitis that often result in difficulty breathing."

Answered by AI

Clinical Trials for Theochron

Have you considered Theochron clinical trials? We made a collection of clinical trials featuring Theochron, we think they might fit your search criteria.
Have you considered Theochron clinical trials? We made a collection of clinical trials featuring Theochron, we think they might fit your search criteria.
Have you considered Theochron clinical trials? We made a collection of clinical trials featuring Theochron, we think they might fit your search criteria.